Trial Search Results
Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion
High-frequency, high-intensity transcutaneous electrical nerve-stimulation (TENS) is an inexpensive and non-invasive pain control approach. TENS, pulsating electrical currents that activate underlying nerves, does not have drug interactions or risk of overdose. Cochrane review of TENS for acute pain found inconclusive evidence. One previous abortion trial comparing TENS to IV sedation only looked at pain control in the recovery room. The investigators propose a randomized controlled trial comparing TENS to IV sedation (in conjunction with local anesthesia) among women presenting for first-trimester surgical abortion. Primary outcome will be perceived pain by Visual Analogue Scale (VAS) during aspiration.
Stanford is currently not accepting patients for this trial.
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Intervention(s):
- Device: Transcutaneous electrical nerve stimulation (TENS)
- Drug: Moderate IV Sedation
- Other: SHAM: Transcutaneous electrical nerve stimulation (TENS)
- Other: SHAM: Moderate IV Sedation
Phase:
N/A
Eligibility
Inclusion criteria:
- Presenting for surgical abortion
- Gestational age <12 weeks
- < 18 years of age
- Agrees to be randomized
Exclusion criteria:
- Allergy to study medications (lidocaine, fentanyl, midazolam)
- > 18 years of age
- Fetal demise
- Pre-procedure use of misoprostol
- No means of transportation following procedure
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Not Recruiting